Uroxatral

In the US, Uroxatral (alfuzosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia.

US matches:

• Uroxatral

Ingredient matches for Uroxatral

Alfuzosin

Alfuzosin hydrochloride (a derivative of Alfuzosin) is reported as an ingredient of Uroxatral in the following countries:

• Argentina


• Chile


• Germany


• United States

International Drug Name Search